Foresite Capital Management IV, LLC, 10% Owner at Eikon Therapeutics, Inc. (EIKN), bought 55,555 shares at $18.00 ($1000K) on 2026-02-04, disclosed to the SEC on 2026-02-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| AERI | BUY | 2019-08-20 | $3.8M | — | Filing → |